Analysis of 15,115 immune and non-immune cells from primary tumors and liver metastases of 18 colorectal cancer (CRC) patients, using two single-cell RNA sequencing technologies (Smart-seq2 and DNBelab C4), revealed that IgA promotes tumor progression (58). Here, CD79A is linked to colorectal carcinoma.